Latest filing published 05 Jun 2026 for Xenon Pharmaceuticals Inc..
Filing timeline
BuySaleInsider track record
Elizabeth Garofalo: trading record in brief
Elizabeth Garofalo discloses dealings in Xenon Pharmaceuticals Inc. to SEC (Form 4). In total, 8 filings cover trades dated from 3 June 2021 to 3 June 2026.
Both buying and selling appear: 1 purchase worth €44k, against 2 sales worth €109k. Taken together, the sales exceed the purchases by €65k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant and 3 option exercises.
The newest entry dates from 5 June 2026: a share grant, in Xenon Pharmaceuticals Inc. The most recent open-market purchase was published on 13 March 2024, 972 days ago. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Elizabeth Garofalo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,593 sharesRestricted Share UnitsTSXSEDI:4730435
- 10,507 sharesOptionsTSXSEDI:4730431
- 2,645 sharesCommon SharesTSXSEDI:4730424
- 2,645 sharesRestricted Share UnitsTSXSEDI:4730421
- Common SharesTSXSEDI:4278414
- 2,092 shares@ CA$45.6942.4% of flowCommon SharesTSXSEDI:4278445
- 1,408 shares@ CA$46.1628.8% of flowCommon SharesTSXSEDI:4278442
- 3,500 shares@ CA$18.5628.8% of flowCommon SharesTSXSEDI:4278438Canonical exit: 6 Jun 2024 (T+90)
8 of 8 declarations
